Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.

NCT02834559 is registered in ClinicalTrials.gov with Universitätsklinikum Köln as lead sponsor.

NCT NCT02834559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02834559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
Lead sponsor
Universitätsklinikum Köln
Phase
Phase 3
Overall status
Completed
Start date
October 27, 2016
Completion date
June 15, 2020
Enrollment
326 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk for proliferative vitreoretinopathy (pvr), rhegmatogenous retinal detachment